Cytokeratin 13 Antikörper (FITC)
Kurzübersicht für Cytokeratin 13 Antikörper (FITC) (ABIN7855537)
Target
Alle Cytokeratin 13 (KRT13) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Cytokeratin 13 Monoclonal Antibody [AE8] - Fluorescein (FITC)
-
Aufreinigung
- Protein G purified
-
Immunogen
- Rabbit esophageal keratins
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Optimal antibody dilution should be determined by titration, however as guideline try at WB: 1/1000 - 1/3000. Predicted molecular weight: 50 kDa
-
Kommentare
-
Myeloma/fusion partners:P3 x 63 Ag8 myeloma cells,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS 0.1 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
-
Andere Bezeichnung
- Cytokeratin 13
-
Hintergrund
- Type I cytoskeletal 13 antibody,47 kDa cytokeratin antibody,CK 13 antibody,CK-13antibody,CK13 antibody,Cytokeratin 13 antibody,Cytokeratin-13 antibody,Cytokeratin13 antibody,K13antibody,K1C13_HUMAN antibody,Ka13 antibody,Keratin 13 antibody,Keratin antibody,keratin type Icytoskeletal 13 antibody,Keratin-13 antibody,Keratin13 antibody,KRT 13 antibody,Krt-1.13 antibody,Krt1-13antibody,KRT13 antibody,MGC161462 antibody,MGC3781 antibody,Type I keratin Ka13 antibody
-
Gen-ID
- 3860, 16663
Target
-